n3PUFAs vs placebo
Depressive symptomology (continuous) HDRS where possible; higher scores indicate greater symptomology · adults with Major Depressive Disorder
1 finding from 1 review
- no estimate extracted33 studies · 1848 participantsVery low
It is very uncertain whether n3PUFAs changes adverse eventsStudy reports compared with placebo (very low certainty).
n3PUFAs showed no clear difference in depressive symptomology (dichotomous ‐ remission)Depressive… compared with placebo (low certainty).
n3PUFAs showed no clear difference in depressive symptomology (dichotomous ‐ response)Depressive… compared with placebo (low certainty).
It is very uncertain whether n3PUFAs changes trial non‐completionStudy reports compared with placebo (very low certainty).